Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long noncoding RNA cancer susceptibility candidate 2 suppresses papillary thyroid carcinoma growth by inactivating the AKT/ERK1/2 signaling pathway

Published:2019-01-04 Issue:6 Volume:120 Page:10380-10390
ISSN:0730-2312
Container-title:Journal of Cellular Biochemistry
language:en
Short-container-title:J Cell Biochem

Author:

Huang Fei¹,Zhang Qing²,Chen Wei³,Zhang Huiting²,Lu Guofen²,Chen Jingyu²,Qiu Changhong²^ORCID

Affiliation:

1. Department of General Surgery The Seventh Affiliated Hospital of Sun Yat‐Sen University Shenzhen China

2. Department of General Surgery The First People's Hospital of Zhaoqing Zhaoqing Guangdong China

3. Department of Pathology The First People's Hospital of Zhaoqing Zhaoqing Guangdong China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcb.28322

Reference31 articles.

1. Thyroid Cancer in Young Adults

2. Worldwide Increasing Incidence of Thyroid Cancer: Update on Epidemiology and Risk Factors

3. Thyroid Cancer: Burden of Illness and Management of Disease

4. Central Neck Dissection for Papillary Thyroid Cancer

5. Central Neck Dissection for Papillary Thyroid Cancer

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress in long non-coding RNAs as prognostic factors of papillary thyroid carcinoma;Pathology - Research and Practice;2024-04

2. LINC00641 impeded the malignant biological behaviors of papillary thyroid carcinoma cells via interacting with IGF2BP1 to reduce GLI1 mRNA stability;Human & Experimental Toxicology;2023-06-08

3. Long non-coding RNA CASC2 inhibits malignant progression of endometrial cancer by negatively regulating mir-103a-3p/mir-107;2023-04-12

4. The Role of Genetic Polymorphisms in Differentiated Thyroid Cancer: A 2023 Update;Biomedicines;2023-04-02

5. Genomic and epigenomic profile of thyroid cancer;Best Practice & Research Clinical Endocrinology & Metabolism;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3